No abstract available
Keywords:
congenital heart defects; fusion; maternal diabetes; mitochondria.
PubMed Disclaimer
Conflict of interest statement
Dr Reddy is supported by an Additional Ventures Foundation grant, a Maternal Child Health Research Institute Faculty Scholar Award, and National Heart, Lung, and Blood Institute grant 1 R01 HL165245.
References
-
-
Lopez K.N., Morris S.A., Tejtel S.K.S., Espaillat A., Salemi J.L. US mortality attributable to congenital heart disease across the lifespan from 1999 through 2017 exposes persistent racial/ethnic disparities. Circulation. 2020;142:1132–1147.
-
PMC
-
PubMed
-
-
Ibrahim S., Gaborit B., Lenoir M., Collod-Beroud G., Stefanovic S. Maternal pre-existing diabetes: a non-inherited risk factor for congenital cardiopathies. Int J Mol Sci. 2023;24(22) doi: 10.3390/ijms242216258.
-
DOI
-
PMC
-
PubMed
-
-
Øyen N., Diaz L.J., Boyd H.A., Pr, et al. Prepregnancy diabetes and offspring risk of congenital heart disease: a nationwide cohort study. Circulation. 2016;133:2243–2253.
-
PMC
-
PubMed
-
-
Liu X., Guo C., Zhang Q. Novel insights into the involvement of mitochondrial fission/fusion in heart failure: from molecular mechanisms to targeted therapies. Cell Stress Chaperones. 2023;28(2):133–144.
-
PMC
-
PubMed
-
-
Wang G., Lu W., Shen W.-B., Karbowski M., Kaushal S., Yang P. Small molecule activators of mitochondrial fusion prevent congenital heart defects induced by maternal diabetes. J Am Coll Cardiol Basic Trans Science. 2024;9(3):303–318.
-
PMC
-
PubMed